Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3(R)-HYDROXYMETHYL-4-BENZYLMORPHOLINE is a morpholine derivative with the molecular formula C12H17NO2, featuring a hydroxymethyl and benzyl group. It is a chemical compound used in the synthesis of pharmaceuticals and agrochemicals as a reagent and intermediate.
Used in Pharmaceutical Industry:
3(R)-HYDROXYMETHYL-4-BENZYLMORPHOLINE is used as a reagent and intermediate for the synthesis of various drugs and compounds. Its morpholine structure, which is commonly found in a variety of bioactive molecules, makes it a promising candidate for medicinal chemistry applications.
Used in Agrochemical Industry:
3(R)-HYDROXYMETHYL-4-BENZYLMORPHOLINE is also used as a reagent and intermediate in the synthesis of agrochemicals, contributing to the development of new and effective products for agricultural use.
The chemical properties and structure of 3(R)-HYDROXYMETHYL-4-BENZYLMORPHOLINE make it an important building block for the production of various drugs and compounds, highlighting its significance in both the pharmaceutical and agrochemical industries.

441717-93-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 441717-93-7 Structure
  • Basic information

    1. Product Name: 3(R)-HYDROXYMETHYL-4-BENZYLMORPHOLINE
    2. Synonyms: 3(R)-HYDROXYMETHYL-4-BENZYLMORPHOLINE;Zinc04202899;(R)-4-Cbz-3-hydroxyMethylMorpholine;(3R)-3-(Hydroxymethyl)-4-morpholinecarboxylic Acid Phenylmethyl Ester;(3R)-3-(Hydroxymethyl)-4-morpholinecarboxylic Acid Phenylmethyl Ester,99%e.e.
    3. CAS NO:441717-93-7
    4. Molecular Formula: C13H17NO4
    5. Molecular Weight: 207.27
    6. EINECS: N/A
    7. Product Categories: pharmacetical
    8. Mol File: 441717-93-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3(R)-HYDROXYMETHYL-4-BENZYLMORPHOLINE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3(R)-HYDROXYMETHYL-4-BENZYLMORPHOLINE(441717-93-7)
    11. EPA Substance Registry System: 3(R)-HYDROXYMETHYL-4-BENZYLMORPHOLINE(441717-93-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 441717-93-7(Hazardous Substances Data)

441717-93-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 441717-93-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,1,7,1 and 7 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 441717-93:
(8*4)+(7*4)+(6*1)+(5*7)+(4*1)+(3*7)+(2*9)+(1*3)=147
147 % 10 = 7
So 441717-93-7 is a valid CAS Registry Number.

441717-93-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name [(3R)-4-benzylmorpholin-4-ium-3-yl]methanol

1.2 Other means of identification

Product number -
Other names (R)-benzyl 3-(hydroxymethyl)morpholine-4-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:441717-93-7 SDS

441717-93-7Relevant articles and documents

MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE

-

Paragraph 0244, (2020/05/15)

The present disclosure relates to compounds of the general formula (I) and pharmaceutical compositions containing them. The compounds are suitable as modulators of hemoglobin and thus useful in treating disorders mediated by hemoglobin such as sickle cell disease.

NOVEL HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 47, (2013/07/05)

The invention provides compounds of formula (I): wherein Rings A and A' are independently 5-membered optionally substituted aromatic heterocycles; Q is C(=O)NR1R1' or formula U is C(R4)2, O, S, S(=O)2, C(R4)2C(R4)2, CH2O, OCH2, CH2S, SCH2, CH2S(=O)2, S(=O)CH2 or C=C(Ru )2; X is CH2, CHR12, CR12R12, O, S, S(=O)2 or NRx; m is 0, 1, 2 or 3; n is 0, 1, 2 or 3; the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 441717-93-7